scispace - formally typeset
S

Satoru Miyano

Researcher at Tokyo Medical and Dental University

Publications -  874
Citations -  45801

Satoru Miyano is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: Gene & Gene regulatory network. The author has an hindex of 84, co-authored 811 publications receiving 38723 citations. Previous affiliations of Satoru Miyano include University of Paderborn & Institute of Medical Science.

Papers
More filters
Journal ArticleDOI

A comprehensive characterization of cis-acting splicing-associated variants in human cancer.

TL;DR: A statistical framework is developed to systematically identify SAVs disrupting or newly creating splice site motifs and applied it to matched whole-exome and transcriptome sequencing data from 8976 samples across 31 cancer types, generating a catalog of 14,438 S AVs.
Journal ArticleDOI

Simulation-based model checking approach to cell fate specification during Caenorhabditis elegans vulval development by hybrid functional Petri net with extension

TL;DR: The quantitative simulation-based model checking approach is a useful means to provide valuable biological insights and better understandings of biological systems and observation data that may be hard to capture with the qualitative one.
Journal ArticleDOI

Bio-calculus: Its Concept and Molecular Interaction.

TL;DR: This paper designs the bio-calculus, a syntax which is similar to conventional expressions in biology and at the same time specifies information needed for simulation analysis, and shows the practicality of bio-Calculus by describing and simulating some molecular interactions with bio- Calculus.
Journal ArticleDOI

Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis.

TL;DR: In this article, a combination of targeted sequencing of 23 clonal hematopoiesis (CH)-related genes and array-based CNA detection of blood-derived DNA was used to delineate the landscape of CH-related SNVs/indels and CNAs in 11,234 individuals without malignancies and 672 individuals with subsequent malignancy.